Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

The latest report from Acumen Research And Consulting highlights that the global Compound Management Market is on a strong ...

“For scientists driving the next breakthrough in antibody or cell therapy, speed is crucial, and no instrument can rival the speed of the iQue ® HTS Platform,” says Jonah Riddell, Product Manager of ...

Creative Biolabs streamlines bispecific antibody development by merging genetic engineering, cell-free expression, and high-throughput screening into a single, comprehensive pipeline.

High-throughput process development (HTPD) based on combining digital twins and experimental results speeds process development and helps scientists perform more screenings with fewer experiments. A ...